Cargando…
Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead
SIMPLE SUMMARY: We have previously shown that overexpression of BST-2 in breast cancer cells promotes cancer cell adhesion and aggressiveness. Although the level of BST-2 in breast tumors is higher than those of established cancer markers, there is no therapy targeting BST-2 in cancer cells. Thus, w...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563317/ https://www.ncbi.nlm.nih.gov/pubmed/32872253 http://dx.doi.org/10.3390/cancers12092448 |